Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. BCTXW.NASDAQ

BriaCell Therapeutics Corp (BCTXW NASDAQ) stock market data APIs

$0.1633 -0.05(-23.8%) as of July 26, 2024
Price chart is built with Anychart

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

BriaCell Therapeutics Corp Financial Data Overview

0.2099
0.1633
-
0.2255
0.1605
0.1055-3.3
48 084 K
0
0
1.912
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BCTXW',
Type: 'Common Stock',
Name: 'BriaCell Therapeutics Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZF3B328',
ISIN: NULL,
CUSIP: NULL,
CIK: '1610820',
EmployerIdNumber: NULL,
FiscalYearEnd: 'July',
IPODate: '2021-02-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Warrant',
IsDelisted: false,
}

BriaCell Therapeutics Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -35 252 612
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get BriaCell Therapeutics Corp Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get BriaCell Therapeutics Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BriaCell Therapeutics Corp latest news via APIs

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

After only 3 cycles, patient experienced a remarkable improvement of eye-bulging “proptosis” caused by orbital metastatic breast cancer tumor behind the eye. Significant ocular pain reduction reco...
  • BRIACELL THERAPEUTICS CORP
  • HEALTH
  • TORONTO STOCK EXCHANGE:BCT

BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND

BriaCell demonstrates unprecedented broad immune system activation in tumor models by BriaCell’s next generation breast and prostate cancer immunotherapies Data supports further development of BriaC...
  • BRIACELL THERAPEUTICS CORP
  • CALENDAR OF EVENTS
  • TORONTO STOCK EXCHANGE:BCT
Do you have any questions?
support@eodhistoricaldata.com